PHARMACY COMPOUNDING OF BULK DRUG SUBSTANCES TO BE TOPIC OF FEDERAL REGISTER NOTICE, FDA SAYS; COMPOUNDING WORKING GROUP ASSEMBLING ADVISORY CMTE.
Executive Summary
FDA will request advice about which bulk drug substances may be used in pharmacy compounding in an upcoming Federal Register notice, the agency said in a statement to industry posted on its Web site.